SOPHARMA AD: Sopharma monthly September 2016

opublikowano: 2016-10-05 13:16

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załącznikĂłw:
Sopharma_monthly_September_2016.doc  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 92 / 2016
Date of issue: 2016-10-05
Short name of the issuer
SOPHARMA AD
Subject
Sopharma monthly September 2016
Official market - legal basis
art. 17. 1 MAR.
Unofficial market - legal basis
Contents of the report:
For the first nine months of this year, revenues from sales decreased by 3% compared to the same period of 2015, including 1% increase of domestic sales and a 5% decrease of export sales. “We are witnessing a positive trend in September, but it is hard to forecast whether it will be stable. However, we managed to a certain extent to compensate the weaker performance of the Russian market in the first half of this year.”, comments Ognian Donev, PhD, Chariman of the Board of Directors and Executive director of Sopharma AD.
Annexes
File Description
Sopharma monthly September 2016.docSopharma monthly September 2016.doc Sopharma monthly September 2016

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2016-10-05 Ognian Donev Executive director